Document Detail


Cell cycle-specific behavior of erythropoietin.
MedLine Citation:
PMID:  8641335     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The murine erythropoietin-dependent erythroleukemia cell line, HCD-57, was employed to study the cell cycle-specific behavior of erythropoietin. Cell cycle duration for HCD-57 cells was approximately 12 hours and was uninfluenced by erythropoietin. Populations of HCD-57 cells synchronized in G1 by centrifugal elutriation were able to pass through one complete cell cycle in the absence of erythropoietin but, thereafter, arrested in G1 as identified by propidium iodide staining and flow cytometry. Analysis of cell cycle behavior using the metachromic dye acridine orange, however, revealed that HCD-57 cells pass through a G0 cell cycle phase and, like serum-deprived 3T3 cells, actually arrest in G0 when deprived of erythropoietin. Expression of the cell cycle regulatory protein p34cdc2 was invariant throughout the cell cycle in HCD-57 cells. p34cdc2 was constitutively phosphorylated in G0 cells, and this effect was not modified by erythropoietin. Erythropoietin receptor distribution was log normal in HCD-57 cells in each phase of the cell cycle. The affinity of these surface receptors for erythropoietin was essentially invariant throughout the cell cycle, but receptor expression was upregulated in G2M cells as compared with cells in G1 or S phase. Taken together, these data indicate that erythropoietin has an important role in the G0-G1 to S phase transition but, based on receptor expression, is involved in other phases of the cell cycle as well.
Authors:
J L Spivak; D K Ferris; J Fisher; S J Noga; M Isaacs; E Connor; W D Hankins
Related Documents :
7861225 - Paradoxical elevation of ki-67 labeling with protein kinase inhibition in malignant gli...
9677325 - Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (fnk) durin...
16437745 - Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell...
1639135 - Lithium mimics dexamethasone in stimulating dna synthesis by wi-38 cells.
16834535 - Profiling activities of transcription factors in breast cancer cell lines.
2896355 - Nonrandom x chromosome inactivation in b cells from carriers of x chromosome-linked sev...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Experimental hematology     Volume:  24     ISSN:  0301-472X     ISO Abbreviation:  Exp. Hematol.     Publication Date:  1996 Feb 
Date Detail:
Created Date:  1996-07-17     Completed Date:  1996-07-17     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0402313     Medline TA:  Exp Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  141-50     Citation Subset:  IM    
Affiliation:
Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
CDC2 Protein Kinase / metabolism
Cell Cycle / drug effects*
Erythropoietin / pharmacology*
Fibroblasts / drug effects
Flow Cytometry
G0 Phase / drug effects
G1 Phase / drug effects
Leukemia, Erythroblastic, Acute / pathology
Mice
Mice, Inbred BALB C
Neoplasm Proteins / metabolism
Receptors, Erythropoietin / metabolism
S Phase / drug effects
Tumor Cells, Cultured / drug effects
Grant Support
ID/Acronym/Agency:
DK16702/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Neoplasm Proteins; 0/Receptors, Erythropoietin; 11096-26-7/Erythropoietin; EC 2.7.11.22/CDC2 Protein Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homing of fluorescently labeled murine hematopoietic stem cells.
Next Document:  Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of t...